Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat COPD (EU)(?)

Council Members in this Study Group: 78

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Hossein Ghofrani, MD, Physician, Justus Liebig Universitat GiessenHossein Ghofrani, MD
Physician
Justus Liebig Universitat Giessen

Hossein Ardeschir (Ardi) Ghofrani, MD, is Lead physician of the Pulmonary Hypertension Centre at the University of Giessen Lung Center (UGLC), Germany. Prof. Ghofrani is a Reviewer for various high impact scientific journals including Lancet, AJRCCM, Circulation, and Circulation research amongst others....

Yves Dauvilliers, MD
Head of Sleep Medicine
Montpellier University Hospital Center

Yves Dauvilliers, MD, is Division Head of Sleep Medicine at the University Hospital of Montpellier, France. Dr. Dauvilliers has expertise in the treatment of all sleep disorders. His basic research interests, using electrophysiological and genetic techniques, are narcolepsy, parasomnia and sleep with...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
False economy by companies | 08-27-2008
Analysis of: Healthways' Guidance Not So Healthy | www.forbes.com
Author: GLG Expert Contributor

Healthways is currently struggling, but hopfully this will only be a temporary local difficulty. In the long run Healthways provides a good service

Not too surprising a result | 08-18-2008
Author: GLG Expert Contributor

You can only open up an artery so far. Whether you achieve this with drugs, or a mechanical device doesn't seem to matter as long as the blood gets flowing again.

New Use for old drugs is something good-and called clinical research. | 07-09-2008
Analysis of: One drug, many uses. Good idea? | www.indystar.com
Author: GLG Expert Contributor

This article implicates that, while new uses for old drugs are terrifically attractive for drug companies this somehow lessens the drive for them to find new original substances. Of course it is nice to get a new market without paying USD 500 000 000 which is the going rate for a new drug through all...

Good but not that much better | 01-14-2008
Author: GLG Expert Contributor

This is a good inhaler but there is no current evidence the drug is signifcantly better than spiriva.

Long term weight loss measured in 24 weeks? | 07-26-2007
Author: GLG Expert Contributor

New drugs need 2 year data!

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Owner
  • Physician - Director
  • Professor

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387